Format

Send to

Choose Destination
J Med Econ. 2019 Apr;22(4):381-382. doi: 10.1080/13696998.2019.1576182. Epub 2019 Feb 13.

Reply: RE: a cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy, and Spain.

Author information

1
a Department of Women and Children's Health SDB , Policlinico Abano Terme , Padova , Italy.
2
b Department of Reproductive and Gynaecological Medicine , Instituto Valenciano de Infertilidad (IVI-RMA) , Bilbao , Spain.
3
c Regional Medical Affairs Fertility, Merck Serono S.p.A. , Rome , Italy , an affiliate of Merck KGaA, Darmstadt, Germany.
4
d Freelance HEOR Consultant, Quintiles IMS , Milan , Italy.
5
e Quintiles IMS , Milan , Italy.
6
f Centre for Gynaecology, Endocrinology, and Reproductive Medicine , Ulm and Stuttgart , Germany.
7
g Department of Gynaecology , Jena-University Hospital-Friedrich Schiller University , Jena , Germany.

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center